Key terms
About SEER
Seer, Inc. (California) engages in the development of proprietary engineered nanoparticles to provide access across the proteome. Its Proteograph product suite comprises automation instrument and software, which provides workflow to make proteomic profiling. The company was founded by Philip Ma, Robert S. Langer Jr. and Omid C. Farokhzad on March 16, 2017 and is headquartered in Redwood City, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest SEER news
Mar 06
1:01am ET
New Share Price & Shareholder Rights Risk for Seer, Inc. – What’s the Latest?
Mar 05
8:05am ET
Seer assumed with an Equal Weight at Morgan Stanley
Feb 29
9:40pm ET
Analysts Offer Insights on Healthcare Companies: Seer (SEER) and Biohaven Ltd. (BHVN)
Feb 29
4:12pm ET
Seer sees FY24 revenue $18M-$20M, consensus $19.9M
Feb 29
4:11pm ET
Seer reports Q4 EPS (28c), consensus (37c)
Feb 06
8:08am ET
Seer announces publication of study on Proteograph workflow
No recent press releases are available for SEER
SEER Financials
Key terms
Ad Feedback
SEER Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
SEER Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
